Cure & cancer: cannabis molecule blend research
Cure Pharmaceutical has entered into a strategic collaboration to test and develop potential cancer therapeutics utilising a blend of the cannabis plant-derived terpenes.
Archives for June 11, 2017
CBSET taps CRO CILcare to advance preclinical services
CBSET is expanding its preclinical research service offerings via a partnership with the contract research organization (CRO) CILcare.
Cryoport developing cold chain logistic models for malaria vaccine
Cryoport will design and implement the cryogenic cold chain to support Phase III clinical trials of Sanaria’s investigational malaria vaccines.
Update - BioMarin to hire 50 people at Shanbally
US FDA clears BioMarin to make $380,000-a year Vimizim in Ireland
The US FDA has cleared BioMarin Pharmaceutical Inc. to make the enzyme replacement drug Vimizim (elosulfase alfa) at its plant in Cork, Ireland.
ABPI wants UK minority Government to put pharma at heart of Brexit talks
Pharmaceuticals should be at the heart of Brexit talks says the Association of the British Pharmaceutical Industry, which has pledged to work with the UK’s minority Government.
Lubrizol invests $60m in drug production at Particle Science plant
The Lubrizol Corporation has invested $60m (€53m) in its Particle Science drug manufacturing business.
B-MS recalls US Eliquis Lot after low dose pills found in 5mg bottle
Bristol Myers Squibb (B-MS) has recalled one lot of the oral anti-clotting drug Eliquis in the US after a customer found 2.5mg strength tablets in a bottle labelled as containing 5mg tablets.
Oncology trends: smaller indications and greater efficiency, says QuintilesIMS Institute
As pharma targets smaller indications and becomes more efficient, oncology clinical trial duration – and patient enrollment – have decreased.